Södertälje, Sweden

Anna Minidis

USPTO Granted Patents = 5 


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Södert{hacek over (a)}lje, SE (2008)
  • Södertälje, SE (2006 - 2017)

Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Minidis

Introduction

Anna Minidis is a prominent inventor based in Södertälje, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cognitive impairments and related disorders. With a total of 5 patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

Among her latest patents, Anna has developed Mono-fluoro beta-secretase inhibitors. These inhibitors are designed to address Aβ-related pathologies, including Down's syndrome and Alzheimer's disease. The pharmaceutical compositions she has created aim to treat cognitive impairments and neurodegeneration associated with various forms of dementia. Additionally, she has patented a novel process for the preparation of cyclopropyl carboxylic acid esters and derivatives. This process is crucial for synthesizing pharmaceutically active entities, showcasing her innovative approach to drug development.

Career Highlights

Anna Minidis is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to collaborate with other experts in the field and contribute to groundbreaking research. Her work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Throughout her career, Anna has worked alongside notable colleagues such as Adrian Clark and Elfyn Jones. These collaborations have further enhanced her research and development efforts, leading to significant advancements in her field.

Conclusion

Anna Minidis exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations are paving the way for new treatments that could greatly benefit individuals suffering from cognitive impairments and related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…